SOLICITATION NOTICE
A -- Assay Development for Superior Understanding of Response and Efficacy (ASSURE)
- Notice Date
- 11/17/2025 10:14:38 AM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ Washington DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- RRPV-26-07-ASSURE
- Response Due
- 12/18/2025 10:00:00 AM
- Archive Date
- 01/02/2026
- Point of Contact
- Rebecca Harmon, Phone: 843.760.3358
- E-Mail Address
-
rebecca.harmon@ati.org
(rebecca.harmon@ati.org)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- The ASSURE program aims to develop innovative, multiplexed, high-throughput, scalable and sample sparing assays that provide comprehensive evaluation of an individual�s immune status as a response to either infection or vaccination. This program seeks to de-risk the development of novel assay platform technologies with the ultimate goal of establishing new, qualified assays primarily for BARDA and vaccine developers to comprehensively assess the immune response and status elicited by vaccines and/or infection due to CBRN threats, pandemic influenza, or other emerging infectious diseases. Some of these assays may lead to support of new correlates of protection.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/774b1c03c1b544e0b086a28eede6b5c8/view)
- Place of Performance
- Address: SC 29486, USA
- Zip Code: 29486
- Country: USA
- Zip Code: 29486
- Record
- SN07643468-F 20251119/251117230035 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |